» Articles » PMID: 23322114

Neuropathic Pain: Role for Presynaptic T-type Channels in Nociceptive Signaling

Overview
Journal Pflugers Arch
Specialty Physiology
Date 2013 Jan 17
PMID 23322114
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Pain is an important clinical problem and, in its chronic form, may be a disabling condition. Most currently available therapies are insufficient and/or accompanied by serious side effects. Recent studies have implicated the CaV3.2 isoform of T-type Ca channels in nociceptive signaling. CaV3.2 channels are located in the somas of dorsal root ganglion cells and in the central endings of these cells in the dorsal horn of the spinal cord. These channels can support the development and maintenance of both physiological (nociceptive) and pathological (neuropathic) pain. In this review, we summarize the most recent evidence linking the presynaptic CaV3.2 channels to the etiology of neuropathic pain disorders. In particular, we focus on data linking plasticity of CaV3.2 channels with neuropathic pain disorders associated with mechanical peripheral nerve injury and with diabetic peripheral neuropathy. We also discuss the development of potential pain therapies aimed at these channels.

Citing Articles

Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity.

Pozzi E, Terribile G, Cherchi L, Di Girolamo S, Sancini G, Alberti P Int J Mol Sci. 2024; 25(12).

PMID: 38928257 PMC: 11203899. DOI: 10.3390/ijms25126552.


Interleukin-22 receptor 1-mediated stimulation of T-type Ca channels enhances sensory neuronal excitability through the tyrosine-protein kinase Lyn-dependent PKA pathway.

Cai H, Chen S, Sun Y, Zheng T, Liu Y, Tao J Cell Commun Signal. 2024; 22(1):307.

PMID: 38831315 PMC: 11145867. DOI: 10.1186/s12964-024-01688-6.


Inhibition of N-type calcium channels by phenoxyaniline and sulfonamide analogues.

Bispat A, Cardoso F, Hasan M, Dongol Y, Wilcox R, Lewis R RSC Med Chem. 2024; 15(3):916-936.

PMID: 38516585 PMC: 10953480. DOI: 10.1039/d3md00714f.


Diabetes-Induced Amplification of Nociceptive DRG Neuron Output by Upregulation of Somatic T-Type Ca Channels.

Ivasiuk A, Matvieienko M, Kononenko N, Duzhyy D, Korogod S, Voitenko N Biomolecules. 2023; 13(9).

PMID: 37759720 PMC: 10526307. DOI: 10.3390/biom13091320.


Adiponectin receptor 1-mediated stimulation of Cav3.2 channels in trigeminal ganglion neurons induces nociceptive behaviors in mice.

Zhang Y, Wei Y, Zheng T, Tao Y, Sun Y, Jiang D J Headache Pain. 2023; 24(1):117.

PMID: 37620777 PMC: 10463856. DOI: 10.1186/s10194-023-01658-2.


References
1.
Nelson M, Woo J, Kang H, Vitko I, Barrett P, Perez-Reyes E . Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J Neurosci. 2007; 27(31):8250-60. PMC: 6673068. DOI: 10.1523/JNEUROSCI.1800-07.2007. View

2.
Latham J, Pathirathna S, Jagodic M, Choe W, Levin M, Nelson M . Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes. 2009; 58(11):2656-65. PMC: 2768156. DOI: 10.2337/db08-1763. View

3.
Cardenas C, Del Mar L, Scroggs R . Variation in serotonergic inhibition of calcium channel currents in four types of rat sensory neurons differentiated by membrane properties. J Neurophysiol. 1995; 74(5):1870-9. DOI: 10.1152/jn.1995.74.5.1870. View

4.
Dogrul A, Gardell L, Ossipov M, Tulunay F, Lai J, Porreca F . Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain. 2003; 105(1-2):159-68. DOI: 10.1016/s0304-3959(03)00177-5. View

5.
Todorovic S, Lingle C . Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J Neurophysiol. 1998; 79(1):240-52. DOI: 10.1152/jn.1998.79.1.240. View